Phio Pharmaceuticals Corp (PHIO)

[sabaidii2]

RXI's business model (dilute ad nauseum until you finally - if ever - get a deal) works great for Dr G. He and the staff continually get stock and options as part of their compensation - which also includes generous salaries.

Investors, however, can only make money if they just happen to buy after the very last dilution and just before a big deal occurs. Good luck timing that right.

So what is the likelihood of pawning off the dross (aka discontinued pipelines) onto other companies? Oh, somewhere between slim and none.